Abstract
We assessed potential predictors of sustained remission for 2 years according to the Disease Activity Score in 28 joints (DAS28)-CRP in patients with rheumatoid arthritis (RA). We obtained data for 290 RA outpatients, from July 2009 to September 2012. Sociodemographic data and answers to questionnaires were collected in face-to-face interviews. Remission was defined according to DAS28-CRP. Sustained remission was defined as meeting criteria for remission in the annual assessment for two consecutive years. Predictive factors of sustained remission according to DAS28-CRP were assessed by univariate and multivariate analyses. Of the 290 RA patients, the baseline remission level, according to DAS28-CRP, was 54.5%. During 2 years of follow-up, the sustained remission rate was 24.5%. RA patients who achieved sustained remission, according to DAS28-CRP, were younger, and had a shorter duration of symptoms, longer period of education, higher monthly income, lower Health Assessment Questionnaire (HAQ) score, lower physician global assessment, lower patient global assessment, lower patient pain assessment, and higher EQ-5D at baseline. Multivariate analyses showed that the baseline HAQ score was independently associated with sustained remission for 2 years according to DAS28-CRP (OR 0.298, 95% CI 0.115–0.770; p = 0.012). A lower HAQ score at baseline was an independent predictor of sustained remission at 2 years, according to DAS28-CRP. Thus, HAQ scores could be useful when stratifying patients according to risk for flare-ups in the clinic.
Similar content being viewed by others
References
Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D, Committee TTE (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4):631–637. doi:10.1136/ard.2009.123919
Radner H, Smolen JS, Aletaha D (2014) Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs. Arthritis Res Ther 16(1):R56. doi:10.1186/ar4491
Ma MH, Scott IC, Kingsley GH, Scott DL (2010) Remission in early rheumatoid arthritis. J Rheumatol 37(7):1444–1453. doi:10.3899/jrheum.091131
Katchamart W, Johnson S, Lin HJ, Phumethum V, Salliot C, Bombardier C (2010) Predictors for remission in rheumatoid arthritis patients: a systematic review. Arthritis Care Res (Hoboken) 62(8):1128–1143. doi:10.1002/acr.20188
Combe B, Logeart I, Belkacemi MC, Dadoun S, Schaeverbeke T, Daures JP, Dougados M (2015) Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort. Ann Rheum Dis 74(4):724–729. doi:10.1136/annrheumdis-2013-204178
Radner H, Alasti F, Smolen JS, Aletaha D (2015) Physical function continues to improve when clinical remission is sustained in rheumatoid arthritis patients. Arthritis Res Ther 17:203. doi:10.1186/s13075-015-0719-x
Lillegraven S, Prince FH, Shadick NA, Bykerk VP, Lu B, Frits ML, Iannaccone CK, Kvien TK, Haavardsholm EA, Weinblatt ME, Solomon DH (2012) Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort. Ann Rheum Dis 71(5):681–686. doi:10.1136/ard.2011.154625
Hamann P, Holland R, Hyrich K, Pauling JD, Shaddick G, Nightingale A, McHugh N (2017) Factors associated with sustained remission in rheumatoid arthritis in patients treated with anti-tumor necrosis factor. Arthritis Care Res (Hoboken) 69(6):783–793. doi:10.1002/acr.23016
Barnabe C, Homik J, Barr SG, Martin L, Maksymowych WP (2014) The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy. J Rheumatol 41(8):1607–1613. doi:10.3899/jrheum.131451
Cook MJ, Diffin J, Scire CA, Lunt M, MacGregor AJ, Symmons DP, Verstappen SM (2016) Predictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register. Rheumatology 55(9):1601–1609. doi:10.1093/rheumatology/kew210
Jayakumar K, Norton S, Dixey J, James D, Gough A, Williams P, Prouse P, Young A, Early Rheumatoid Arthritis S (2012) Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS. Rheumatology 51(1):169–175. doi:10.1093/rheumatology/ker250
Mohammed RH, Farahat F, Kewan HH, Bukhari MA (2015) Predictors of European League Against Rheumatism (EULAR) good response, DAS-28 remission and sustained responses to TNF-inhibitors in rheumatoid arthritis: a prospective study in refractory disease. Springerplus 4:207. doi:10.1186/s40064-015-0979-6
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheumatol 31(3):315–324
Bae SC, Cook EF, Kim SY (1998) Psychometric evaluation of a Korean Health Assessment Questionnaire for clinical research. J Rheumatol 25(10):1975–1979
Kim MH, Cho YS, Uhm WS, Kim S, Bae SC (2005) Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases. Qual Life Res 14(5):1401–1406
Stucki G, Liang MH, Stucki S, Bruhlmann P, Michel BA (1995) A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheumatol 38(6):795–798
Fransen J, Welsing PMJ, De Keijzer RMH, Van Riel PLCM (2003) Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis 62(Suppl 1):151
Wolfe F (2000) A reappraisal of HAQ disability in rheumatoid arthritis. Arthritis Rheumatol 43(12):2751–2761. doi:10.1002/1529-0131(200012)43:12<2751:AID-ANR15>3.0.CO;2-6
Wolfe F, Kleinheksel SM, Cathey MA, Hawley DJ, Spitz PW, Fries JF (1988) The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol 15(10):1480–1488
Callahan LF, Bloch DA, Pincus T (1992) Identification of work disability in rheumatoid arthritis: physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables. J Clin Epidemiol 45(2):127–138
van Nies JA, de Jong Z, van der Helm-van Mil AH, Knevel R, Le Cessie S, Huizinga TW (2010) Improved treatment strategies reduce the increased mortality risk in early RA patients. Rheumatology 49(11):2210–2216. doi:10.1093/rheumatology/keq250
Fleischmann R, van der Heijde D, Koenig AS, Pedersen R, Szumski A, Marshall L, Bananis E (2015) How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index? Ann Rheum Dis 74(6):1132–1137. doi:10.1136/annrheumdis-2013-204920
Gaujoux-Viala C, Mouterde G, Baillet A, Claudepierre P, Fautrel B, Le Loet X, Maillefert JF (2012) Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI. Jt Bone Spine 79(2):149–155. doi:10.1016/j.jbspin.2011.04.008
Shaver TS, Anderson JD, Weidensaul DN, Shahouri SH, Busch RE, Mikuls TR, Michaud K, Wolfe F (2008) The problem of rheumatoid arthritis disease activity and remission in clinical practice. J Rheumatol 35(6):1015–1022
Sokka T, Hetland ML, Makinen H, Kautiainen H, Horslev-Petersen K, Luukkainen RK, Combe B, Badsha H, Drosos AA, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M, Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Burmester GR, Tunc R, Dimic A, Nedovic J, Stankovic A, Bergman M, Toloza S, Pincus T, Questionnaires in Standard Monitoring of Patients With Rheumatoid Arthritis G (2008) Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheumatol 58(9):2642–2651. doi:10.1002/art.23794
Forslind K, Hafstrom I, Ahlmen M, Svensson B, Group BS (2007) Sex: a major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis 66(1):46–52. doi:10.1136/ard.2006.056937
Kristensen LE, Kapetanovic MC, Gulfe A, Soderlin M, Saxne T, Geborek P (2008) Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register. Rheumatology 47(4):495–499. doi:10.1093/rheumatology/ken002
Castrejon I, Dougados M, Combe B, Fautrel B, Guillemin F, Pincus T (2016) Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other core data set measures, but not by the absence of rheumatoid factor, anticitrullinated protein antibodies, or radiographic erosions. J Rheumatol 43(7):1285–1291. doi:10.3899/jrheum.141586
Molina E, Del Rincon I, Restrepo JF, Battafarano DF, Escalante A (2015) Association of socioeconomic status with treatment delays, disease activity, joint damage, and disability in rheumatoid arthritis. Arthritis Care Res (Hoboken) 67(7):940–946. doi:10.1002/acr.22542
Thiele K, Huscher D, Bischoff S, Spathling-Mestekemper S, Backhaus M, Aringer M, Kohlmann T, Zink A, German Collaborative Arthritis C (2013) Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis. Ann Rheum Dis 72(7):1194–1199. doi:10.1136/annrheumdis-2012-201821
de Punder YM, Fransen J, Kievit W, Houtman PM, Visser H, van de Laar MA, van Riel PL (2012) The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry. Rheumatology 51(9):1610–1617. doi:10.1093/rheumatology/kes078
Shahouri SH, Michaud K, Mikuls TR, Caplan L, Shaver TS, Anderson JD, Weidensaul DN, Busch RE, Wang S, Wolfe F (2011) Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria. Arthritis Rheumatol 63(11):3204–3215. doi:10.1002/art.30524
Acknowledgements
The authors thank the patients and their families for their participation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
This research complied with the Helsinki Declaration. This study was approved by the Institutional Review Board of CNUH (I-2009-05-049) and informed consent was obtained at the time of registry enrollment.
Conflict of interest
The authors declare that they do not have conflict of interests.
Funding
This study was supported by Celltrion Korea and Bitgoeul Chonnam National University Hospital (BCRI16001-52).
Rights and permissions
About this article
Cite this article
Lee, KE., Choi, SE., Xu, H. et al. HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis. Rheumatol Int 37, 2027–2034 (2017). https://doi.org/10.1007/s00296-017-3833-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-017-3833-z